CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...
Phase 3
Saint Louis, Missouri, United States and 18 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Saint Peters, Missouri, United States and 321 other locations
of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys...
Phase 3
Saint Louis, Missouri, United States and 45 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Saint Louis, Missouri, United States and 236 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Saint Louis, Missouri, United States and 80 other locations
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...
Phase 3
Saint Louis, Missouri, United States and 173 other locations
receptor is known to trigger injury and inflammation in the kidney and is therefore thought to play a role in CKD.Empagliflozin lowers blood...
Phase 2
Saint Louis, Missouri, United States and 210 other locations
The major objective is to demonstrate the safety and efficacy of ANG-3070 in patients with primary glomerular disease and persistent protein...
Phase 2
Saint Louis, Missouri, United States and 28 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
Saint Louis, Missouri, United States and 943 other locations
The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This...
Phase 3
Saint Louis, Missouri, United States and 559 other locations
Clinical trials
Research sites
Resources
Legal